Document Detail


Insulinlike growth factor 1 in controls and growth-retarded fetuses.
MedLine Citation:
PMID:  9708446     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To establish a reference range of insulinlike growth factor 1 (IGF-1) values in normal fetuses and to assess whether intrauterine growth retardation is associated with increased or decreased IGF-1 levels. METHODS: Retrospective analysis of blood samples collected from 64 fetuses who underwent blood sampling at 18-38 weeks' gestation was performed: 40 fetuses, who were considered controls, were appropriately grown for gestational age and were found unaffected by the condition for which they were tested; the remainder (n = 24) underwent fetal blood sampling to assess fetal karyotype and acid-base balance following ultrasonic diagnosis of intrauterine growth retardation. (In this group, 8 survived, and 16 died during the perinatal period). IGF-1 was measured using a radioimmunoassay after acid-ethanol extraction in order to avoid interference by the binding proteins. All samples from controls and growth-retarded fetuses were measured using the same batch, and the intra-assay coefficient of variation of the test ranged from 4.1 to 6.1%. RESULTS: In control fetuses, IGF-1 serum levels increased linearly with gestational age. In growth-retarded fetuses, IGF-1 levels were not significantly different from the reference range (median Z-score -0.3; range -4.4 to 291) and did not correlate with fetal size, hematocrit, and acid-base balance values. There was a significant difference in IGF-1 and pH values when the fetuses were divided into two groups based on the perinatal outcome: those who survived had values of IGF-1 mostly within the normal range, whereas the fetuses who died in utero or postnatally had significantly decreased pH and elevated IGF-1 values (median Z-score 2.1; 95% confidence interval 0.4-13.9; p = 0.04). CONCLUSIONS: This study confirms previous observations that IGF-1 levels parallel the increase in fetal size which occurs with advancing gestation. Increased levels of IGF-1 may indicate a terminal process in the fetal adaptation to placental failure.
Authors:
L Bocconi; F Mauro; S E Maddalena; C De Iulio; A S Tirelli; E Pace; U Nicolini
Related Documents :
1560496 - Varix of the fetal intra-abdominal umbilical vein: comparison with normal.
9605466 - Computer-assisted analysis of fetal movements in intrauterine growth retardation (iugr).
17429666 - Isolated fetal intracardiac hyperechogenic focus associated with neonatal outcome and t...
17003546 - Fetal head biometry assessed by fetal magnetic resonance imaging following in utero mye...
176296 - Control of oestrogen production in human pregnancy: effect of trophic hormones on stero...
18759316 - Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide pr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Fetal diagnosis and therapy     Volume:  13     ISSN:  1015-3837     ISO Abbreviation:  Fetal. Diagn. Ther.     Publication Date:    1998 May-Jun
Date Detail:
Created Date:  1998-10-08     Completed Date:  1998-10-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9107463     Medline TA:  Fetal Diagn Ther     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  192-6     Citation Subset:  IM    
Affiliation:
1st Department of Obstetrics and Gynecology, University of Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Case-Control Studies
Fetal Blood / chemistry*
Fetal Death / blood
Fetal Growth Retardation / blood*
Gestational Age
Humans
Infant Mortality
Infant, Newborn
Insulin-Like Growth Factor I / analysis*
Reference Values
Retrospective Studies
Chemical
Reg. No./Substance:
67763-96-6/Insulin-Like Growth Factor I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chromosomal anomalies in abnormal human pregnancies.
Next Document:  The challenge of p53: linking biochemistry, biology, and patient management.